Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Endocrinology

Long-Term Outlook: Hormones, Cancer Risk, and Fertility

At a Glance

The long-term care for 46,XY DSD focuses on managing gonadal cancer risks, maintaining bone health through lifelong hormone replacement therapy, and addressing fertility. Psychological support is also crucial for navigating emotional well-being, dating, and processing infertility.

As time goes on, the focus of care shifts to supporting long-term health, identity, and future options. While 46,XY Difference of Sex Development (DSD) involves lifelong medical management, most individuals lead healthy, fulfilling lives [1]. Understanding the pillars of long-term care—cancer risk management, hormone health, fertility, and emotional well-being—can help you plan for the future.

Managing Malignancy Risks

A primary medical concern is the risk of gonadal germ cell tumors (GCTs), such as gonadoblastoma or dysgerminoma [2][3]. This risk varies drastically depending on the specific diagnosis:

  • High Risk (Swyer Syndrome/Gonadal Dysgenesis): The gonads do not develop typically and have a significantly higher risk of becoming malignant, even before puberty [4][5]. Doctors often recommend removing the gonads (gonadectomy) [4][6].
  • Variable/Moderate Risk (Partial AIS - PAIS): PAIS carries a higher risk of germ cell tumors than Complete AIS, particularly if the gonads remain in the abdomen [7]. Surgical timing requires careful discussion with the medical team.
  • Low Risk (Complete AIS & 5-Alpha Reductase Deficiency): The cancer risk in CAIS is very low during childhood [8]. Waiting allows the individual to undergo a natural “hormonal” puberty using their own gonads, as testosterone naturally converts to estrogen in the body [7]. Similarly, 5-ARD carries a low cancer risk, comparable to the risk for undescended testes in the general population.
  • Surveillance: If surgery is delayed, regular monitoring through imaging (ultrasound/MRI) and blood tests is required [9].

The Role of Hormone Replacement Therapy (HRT)

Hormones are responsible for far more than physical appearance; they are essential for bone health, cardiovascular health, and emotional well-being [1][10].

If the gonads are removed or do not produce enough hormones, lifelong Hormone Replacement Therapy (HRT) is necessary [11][10].

  • Pubertal Induction: Around the age of puberty, the medical team will start a carefully managed hormone protocol to help develop secondary sex characteristics [12].
  • Bone Health: Without sufficient estrogen or testosterone, bones can become weak (osteoporosis). Consistent HRT is critical to maintain strong bones [1][10].

Fertility and Grieving Infertility

Learning that natural pregnancy is not possible can bring profound feelings of loss and grief. It is important to validate the emotional weight of infertility before rushing to “fix” it with alternatives. Processing this loss with a specialized counselor or peer support group is a crucial step for many patients.

Once ready, it helps to know how modern medicine can assist:

  • CAIS: Because there is no uterus and the gonads do not produce eggs or sperm, natural pregnancy is not possible [13][14]. Families often explore adoption or surrogacy when ready.
  • Swyer Syndrome: Individuals do not produce their own eggs but typically have a uterus. This means they can often carry a pregnancy using In Vitro Fertilization (IVF) with donor eggs [15][16]. With proper hormone support, the uterus can develop and support a healthy pregnancy [17][18].
  • 5-Alpha Reductase Deficiency: Some individuals raised as male may have the potential to produce sperm, though assisted reproductive technology (like ICSI) is often needed [19][20].

Psychological Well-Being, Dating, and Disclosure

Living with a chronic medical condition requires attending to emotional health as rigorously as physical health.

  • Scan Anxiety: Regular medical screenings can cause intense stress [21][22]. Coping strategies and fast-tracking results can mitigate this anxiety [23].
  • Dating and Disclosure: Navigating romantic relationships and deciding when and how to disclose a DSD diagnosis is a common challenge. Patient-led peer support organizations (like Intersex advocacy groups) are invaluable resources for advice on navigating these conversations.
  • Integrated Care: Regular check-ins with a psychologist who specializes in DSD can help process shifting identities, body image, and medical trauma [24][25].

Common questions in this guide

What is the risk of cancer with 46,XY DSD?
The risk of gonadal tumors depends on your specific diagnosis. High-risk conditions like Swyer syndrome often require preventive surgery to remove the gonads, while low-risk conditions like Complete Androgen Insensitivity Syndrome (CAIS) may safely delay surgery with careful monitoring.
Will I need hormone replacement therapy for 46,XY DSD?
Yes, if your gonads are removed or do not produce enough hormones, lifelong hormone replacement therapy is necessary. This treatment helps induce puberty, supports emotional well-being, and is critical for maintaining strong bones and cardiovascular health.
Can someone with 46,XY DSD have children?
While natural pregnancy is generally not possible, options depend on your specific anatomy. Individuals with Swyer syndrome can often carry a pregnancy using IVF with donor eggs, while those with CAIS usually explore alternatives like surrogacy or adoption.
How often should I be monitored if I delay surgery to remove my gonads?
If you and your medical team decide to delay preventive surgery, you will need regular surveillance to watch for early signs of cancer. This typically includes routine imaging like ultrasounds or MRIs, along with specialized blood tests.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific malignancy risk for this diagnosis compared to other 46,XY DSD types?
  2. 2.What is the monitoring schedule (e.g., ultrasound, MRI, or blood markers) if we choose to delay surgery?
  3. 3.When is it time to start or adjust Hormone Replacement Therapy, and what are the specific delivery methods available?
  4. 4.What are the realistic options for future fertility, including assisted reproductive technologies?
  5. 5.Can you recommend a therapist or peer-support group that specializes in DSD and chronic illness monitoring?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    [Advances in the diagnosis and hormone replacement treatment of 46, XY disorders of sex development].

    Tian HJ, Zhang JW, Wu DH, et al.

    Zhonghua nan ke xue = National journal of andrology 2016; (22(9)):843-849.

    PMID: 29071885
  2. 2

    Seminoma in 46, XY Gonadal Dysgenesis: Rare Presentation and Review of the Literature

    Adra M, Nakanishi H, Papachristodoulou E, et al.

    Journal of clinical research in pediatric endocrinology 2024; (16(4)):495-500 doi:10.4274/jcrpe.galenos.2023.2023-12-11.

    PMID: 37074092
  3. 3

    Mixed Germ Cell Tumour in a Case of Pure Gonadal Dysgenesis (Swyer Syndrome) - A Case Report.

    Kumar NP, M V, Mathews A, James FV

    Cureus 2016; (8(1)):e459 doi:10.7759/cureus.459.

    PMID: 26918227
  4. 4

    Gonadal tumor risk in pediatric and adolescent phenotypic females with disorders of sex development and Y chromosomal constitution with different genetic etiologies.

    Lu L, Luo F, Wang X

    Frontiers in pediatrics 2022; (10()):856128 doi:10.3389/fped.2022.856128.

    PMID: 35935368
  5. 5

    Dysgerminoma in a Prepubertal Girl with Complete 46XY Gonadal Dysgenesis: Case Report and Review of the Literature.

    Bumbulienė Ž, Varytė G, Geimanaitė L

    Journal of pediatric and adolescent gynecology 2020; (33(5)):599-601 doi:10.1016/j.jpag.2020.04.007.

    PMID: 32380037
  6. 6

    The laparoscopic management of Swyer syndrome: Case series.

    Malhotra N, Dadhwal V, Sharma KA, et al.

    Journal of the Turkish German Gynecological Association 2015; (16(4)):252-6 doi:10.5152/jtgga.2015.15061.

    PMID: 26692777
  7. 7

    Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls.

    Guaragna-Filho G, Guerra-Junior G, Tadokoro-Cuccaro R, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2023; (17(1)):16-25 doi:10.1159/000526997.

    PMID: 36917969
  8. 8

    Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

    Wang F, Wang D, Li J, Xing N

    Cancer reports (Hoboken, N.J.) 2026; (9(2)):e70491 doi:10.1002/cnr2.70491.

    PMID: 41725111
  9. 9

    Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.

    Steinmacher S, Brucker SY, Kölle A, et al.

    International journal of environmental research and public health 2021; (18(11)) doi:10.3390/ijerph18115648.

    PMID: 34070473
  10. 10

    Complete androgen insensitivity syndrome in twins with discordant phenotypes: a case report and review of the literature.

    Liao K, Wang Y, Yi X

    Journal of medical case reports 2025; (19(1)):113 doi:10.1186/s13256-025-05139-9.

    PMID: 40083004
  11. 11

    Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

    Nordenström A, Ahmed SF, van den Akker E, et al.

    European journal of endocrinology 2022; (186(6)):G9-G49 doi:10.1530/EJE-22-0073.

    PMID: 35353710
  12. 12

    Primary gonadal failure.

    Ladjouze A, Donaldson M

    Best practice & research. Clinical endocrinology & metabolism 2019; (33(3)):101295 doi:10.1016/j.beem.2019.101295.

    PMID: 31327696
  13. 13

    Management of Gonads in Adults with Androgen Insensitivity: An International Survey.

    Tack LJW, Maris E, Looijenga LHJ, et al.

    Hormone research in paediatrics 2018; (90(4)):236-246 doi:10.1159/000493645.

    PMID: 30336477
  14. 14

    18-Year-old patient with Klinefelter syndrome (47, XXY) and complete androgen insensitivity syndrome (CAIS) - case report.

    Skalska K, Ziółkowski M, Skoczylas A, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021; (37(6)):572-575 doi:10.1080/09513590.2021.1921139.

    PMID: 33960260
  15. 15

    Infertility management in a patient with Swyer syndrome: a case report.

    Krygere L, Bartasiene R, Kozlovskaja-Gumbriene A, Drejeriene E

    Journal of assisted reproduction and genetics 2025; (42(5)):1689-1695 doi:10.1007/s10815-025-03442-4.

    PMID: 40097859
  16. 16

    Rare successful pregnancy in a patient with Swyer Syndrome.

    Taneja J, Ogutu D, Ah-Moye M

    Case reports in women's health 2016; (12()):1-2 doi:10.1016/j.crwh.2016.10.001.

    PMID: 29629300
  17. 17

    Perspective on postoperative hormone replacement therapy and fertility preservation in Swyer syndrome with dysgerminoma: a case series and literature review.

    Liang J, Wu T, Feng X, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2026; (317()):114857 doi:10.1016/j.ejogrb.2025.114857.

    PMID: 41317609
  18. 18

    A Successful New Case of Twin Pregnancy in a Patient with Swyer Syndrome-An Up-to-Date Review on the Incidence and Outcome of Twin/Multiple Gestations in the Pure 46,XY Gonadal Dysgenesis.

    Winkler I, Jaszczuk I, Gogacz M, et al.

    International journal of environmental research and public health 2022; (19(9)) doi:10.3390/ijerph19095027.

    PMID: 35564421
  19. 19

    Fertility potential in 5α-reductase type 2 deficient males.

    Markouli M, Michala L

    Journal of pediatric urology 2023; (19(1)):108-114 doi:10.1016/j.jpurol.2022.09.002.

    PMID: 36153242
  20. 20

    Paternity in 5α-Reductase-2 Deficiency: Report of Two Brothers with Spontaneous or Assisted Fertility and Literature Review.

    Bertelloni S, Baldinotti F, Baroncelli GI, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2019; (13(2)):55-59 doi:10.1159/000497400.

    PMID: 30889611
  21. 21

    Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy.

    Lai-Kwon J, Heynemann S, Flore J, et al.

    Journal of cancer survivorship : research and practice 2021; (15(3)):392-397 doi:10.1007/s11764-021-01024-8.

    PMID: 33788170
  22. 22

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  23. 23

    Survey of maternal anxiety and perceptions towards foetal MRI and pre-scan education.

    Plunkett S, Dobeli K, Prior M, Tusek X

    Journal of medical radiation sciences 2024; (71(1)):10-20 doi:10.1002/jmrs.725.

    PMID: 37724764
  24. 24

    The risk of mental disorders in patients with disorders/differences of sex differentiation/development (DSD) and Y chromosome.

    Bajszczak K, Szarras-Czapnik M, Walczak-Jędrzejowska R, et al.

    Endokrynologia Polska 2020; (71(2)):168-175 doi:10.5603/EP.a2020.0005.

    PMID: 32129466
  25. 25

    Fear of giving birth alone: Experiences of psychological distress, symptoms of anxiety and depression, and coping- strategies of childbearing women during COVID-19.

    Johnson MS, Skjerdingstad N, Ebrahimi OV, et al.

    Midwifery 2024; (131()):103951 doi:10.1016/j.midw.2024.103951.

    PMID: 38402661

This page provides general information about the long-term outlook and care for 46,XY DSD for educational purposes only. Always consult your endocrinologist and medical team for personalized advice regarding hormone therapy, cancer screening, and fertility.

Get notified when new evidence is published on 46,XY difference of sex development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.